Markets

Femto Green Hydrogen Ltd. Initiates Research Partnership Discussions with Purdue University Femto Green Hydrogen Ltd., a subsidiary of Indo Thai Securities Limited, has begun research partnership discussions with the Center for Research and Education in Advanced Transportation Ecosystems (CREATE) at Purdue University in Indiana, USA. The discussions are focused on advancing the scientific validation and development of Femto’s technology.Dr. Manoj Patankar, Director of CREATE, has evaluated Femto's proprietary technology for improving diesel fuel efficiency and reducing emissions for the past three years. Research findings, documented in the article “Terahertz Treatment of Automotive Diesel Achieves Consistent Improvements in Fuel...

Senores Pharmaceuticals Appoints New Senior Management, Announces Resignation Senores Pharmaceuticals Limited announced changes to its senior management on Tuesday, March 17, 2026. The company’s Board of Directors approved the appointment of Mr. Jatin Gajjar as a Senior Management Personnel (SMP) and Chief Technology Officer. Mr. Gajjar brings over three decades of leadership experience in pharmaceutical technology, manufacturing operations, and product development.Simultaneously, the company announced that Mr. Manohar Lalge, President - Research and Development, has resigned, effective March 17, 2026. He is also stepping down as an SMP of the company.According to a company statement, Mr. Gajjar’s expertise lies in complex...

GNG Electronics Limited Enhances Working Capital Facility with Kotak Mahindra Bank GNG Electronics Limited announced on March 17, 2026, that it has entered into a supplemental agreement with Kotak Mahindra Bank Ltd. The agreement, effective March 16, 2026, modifies a Master Facility Agreement originally established on July 26, 2024.The purpose of the supplemental agreement is to enhance the overall limit from 51,00,00,000 Indian Rupees to 75,00,00,000 Indian Rupees and to permit interchangeability between the various facilities. The facility will be utilized for meeting the working capital requirements of the company.Here's a summary of the key details:ParticularsDetailsParties InvolvedKotak Mahindra Bank Ltd.Agreement...

A B Infrabuild Limited Receives New Project Orders Worth ₹48.68 Crore A B Infrabuild Limited announced it has received letters of acceptance for two new projects on March 17, 2026.The company secured a contract from East Coast Railways, Indian Railways, for the construction of a Road Over Bridge (ROB) on the Howrah-Vishakhapatnam main line. This project involves the construction of 1x36.0 m composite girder + 2x24.0 m composite girder for the railway portion and 2x24.0 m composite girder outside the railway portion, replacing Level Crossing No.-360 at Km 665/1921 between Mandasa-Summadevi stations. The project’s duration is 24 months, and the contract value is ₹48,67,75,280.22.Additionally, A B Infrabuild Limited has been awarded...

Kumbhat Financial Services Ltd. Addresses Share Price Movement Kumbhat Financial Services Limited clarified on March 17, 2026, regarding a recent movement in its share price. The response follows a communication received from BSE Limited on March 16, 2026, concerning the price activity of the company’s security, Scrip Code 526869.The company stated it is unaware of any specific information or impending announcement that would account for the observed price and volume behavior. Kumbhat Financial Services Limited affirmed its commitment to disclosing all events and information impacting its operations and performance, adhering to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.The company...

Aurobindo Pharma’s Subsidiary Receives ‘Official Action Indicated’ Classification from US FDA Aurobindo Pharma Limited announced on March 17, 2026, that the United States Food and Drug Administration (US FDA) has classified Unit-II of Eugia Pharma Specialities Limited, a wholly owned subsidiary of Aurobindo Pharma, as ‘Official Action Indicated’ (OAI).Eugia Pharma Specialities Limited’s Unit-II, located in the RIICO Industrial Area, Phase -III, Bhiwadi, Rajasthan, was inspected by the US FDA from November 3 to November 14, 2025. Following the inspection, a ‘Form 483’ was issued, detailing nine observations.Aurobindo Pharma stated that it currently does not anticipate any impact on business operations as a result of this...

Gujarat Industries Power Company Limited Appoints Additional Director Gujarat Industries Power Company Limited (GIPCL) announced the appointment of Shri Jenu Devan, IAS, as an Additional Director (Nominee of Government of Gujarat) on March 17, 2026. The appointment was approved by the Board of Directors following a recommendation from the Nomination and Remuneration Committee.Shri Jenu Devan (DIN: 07852736) holds the position of Secretary (Expenditure) in the Finance Department, Government of Gujarat. He is an IAS Officer of the 2006 batch, holding a Master of Commerce from MG University Kottayam and an MA (Public Policy) from Indira Gandhi National Open University. Previously, he served in various roles including District Development...

NPST Secures UPI Switch Mandate from Large Cooperative Bank Under Bank-in-a-Box Platform Mumbai, March 16, 2026 — Network People Services Technologies Limited (NPST), a leading digital banking and payments technology company, announced it has secured a strategic mandate from a large cooperative bank to deploy its UPI Switch infrastructure.The engagement marks NPST’s first order under its Bank-in-a-Box offering, utilizing a plug-and-play model that enables banks to rapidly deploy scalable, enterprise-grade payment infrastructure. This model allows NPST to generate recurring, multi-year, SaaS-based revenue.Through this deployment, the bank will be able to enter the UPI merchant acquiring ecosystem, expand digital payment acceptance...

CARE Ratings Limited Announces Joint Venture to Enable Global Capability Centres CARE Ratings Limited announced the formation of a joint venture, tentatively named 'Operus Limited,' in collaboration with Vestian Global Work Place Services Private Limited. The Strategy and Investment Committee of CARE Ratings approved the incorporation on March 17, 2026.The joint venture aims to provide Global Capability Centre (GCC) enablement services, assisting global enterprises in designing, establishing, and operating GCCs in India. Services will include strategy, operating model design, talent acquisition, workspace setup, and regulatory compliance. Operus will offer managed services and scalable business models aligned with clients' long-term...

De Nora India Limited Board Approves Material Related Party Transactions De Nora India Limited announced on March 17, 2026, that its Board of Directors approved material related party transactions with Industrie De Nora S.p.A., Italy. The transactions are valued at a maximum of Rs. 2,080 lakhs for the financial year 2026-27 and are subject to shareholder approval.The company will be seeking approval from its members through a postal ballot, which will be delivered electronically to registered email addresses as of March 20, 2026.Remote e-voting for the proposed resolution will be available from April 1, 2026, at 9:00 AM (IST) to April 30, 2026, at 5:00 PM (IST). Shareholders holding shares as of the cutoff date of March 20, 2026...

Mangalam Drugs and Organics Limited Discloses Default on Bank Loans Mumbai – March 17, 2026 – Mangalam Drugs and Organics Limited announced today that it has defaulted on loan obligations to Bank of Baroda and Bank of Maharashtra for a period exceeding 30 days. The disclosure is made in accordance with SEBI's Listing Obligations and Disclosure Requirements.As of March 15, 2026, the company has outstanding amounts due to the banks as detailed in the table below:Sr.NoLoan Account Number- Cash Credit A/c. No.Name of BankAmount Overdue (Rs. In Lacs)Date of Start of Default160383561246Bank of Maharashtra9792117/10/2025204170500000243Bank of Baroda606.0820/10/2025The company is currently working to arrange payment of the...

Kilitch Drugs (India) Limited Sets Record Date for Bonus Equity Share Issue Kilitch Drugs (India) Limited has announced a 1:1 bonus equity share issue, meaning one bonus share for every share held. The record date for determining eligible shareholders has been established as Tuesday, March 24, 2026.Shareholders registered with the company's register of members for physical shares, and those held electronically through depositories, as of the closing hours of March 24, 2026, will be entitled to receive the bonus shares. The bonus shares have a face value of 10 Indian Rupees each.According to a filing, the deemed date of allotment for the bonus equity shares will be Wednesday, March 25, 2026, in accordance with a SEBI circular dated...

Bharat Electronics Limited Secures Orders Worth Rs. 1011 Crore Bharat Electronics Limited (BEL), a Navratna Defence Public Sector Undertaking, has secured additional orders worth Rs. 1011 Crore since February 25, 2026.The orders include communication equipment, radar warning and jamming systems, fire control systems, electro optic sights, fire detection & warning systems for fighter aircraft, high energy lasers, automatic train supervision systems, headup displays, software solutions, jammers, shelters, strategic components, upgrades, spares, and services.Source:

Damodar Industries Limited Appoints New Directors and Compliance Officer Damodar Industries Limited announced several key appointments following a board meeting held on March 17, 2026. The meeting commenced at 1:30 PM and concluded at 3:15 PM.Among the decisions made, the company appointed Mr. Suresh Narayan Nayak as an additional director in the Non-Executive Independent category. Mr. Nayak’s appointment is effective March 17, 2026, and his term will continue until March 16, 2031, subject to shareholder approval. Mr. Nayak brings expertise in banking operations, retail banking, and RBI compliance. He has held leadership roles with YES BANK, Axis Bank, HDFC Bank, and Syndicate Bank.Additionally, the board appointed Vishal N Manseta...

Bajaj Healthcare Limited Announces Sale of Undertaking to Bethany Pharmacare Bajaj Healthcare Limited announced on March 17, 2026, that it has signed a Deed of Assignment and Transfer with Bethany Pharmacare Private Limited for the sale of an undertaking located at Plot No. L-9/3, MIDC, Tarapur, Taluka Boisar, District Palghar, Maharashtra.The transaction, which does not involve any related parties, will result in a consideration of approximately Rs. 2.50 Crores. The completion of the sale is contingent upon the fulfillment of conditions outlined in the Deed of Assignment and Transfer.The undertaking was not operational during the last financial year, resulting in nil turnover or revenue contribution.Shareholders had previously...

Ethos Limited Opens New Boutique in Kanpur, Expanding Retail Presence Ethos Limited has inaugurated a new Ethos Watch Boutique in Kanpur, Uttar Pradesh, marking a key step in the company’s strategy to expand its luxury retail footprint. The new boutique is located at G-12 & 13, Z square, Mall Rd, Downtown, Kanpur, Uttar Pradesh 208001.This expansion strengthens Ethos Limited’s luxury brand portfolio and reinforces its position within a prominent luxury retail market in India. The company aims to make exclusive global brands more accessible to discerning customers across the country.With this latest launch, Ethos Limited now operates a total of 91 boutiques throughout India.Shubham Kandhway, Company Secretary & Compliance Officer...

Gravity India Ltd. Receives In-Principle Approval for Rights Issue Gravity India Ltd. announced on March 17, 2026, that it has received in-principle approval from the Bombay Stock Exchange (BSE) for a proposed rights issue of equity shares. The approval was conveyed in a letter dated March 16, 2026, reference number LOD/RIGHT/HC/FIP/1893/2025-26.The BSE’s permission allows Gravity India Ltd. to use the exchange's name in its Letter of Offer, provided the company includes a disclaimer clause as outlined by the BSE in all related advertisements. The BSE clarified that this permission does not constitute a certification of the contents of the Letter of Offer or guarantee the listing or continued listing of the company's securities.The...

Setco Automotive Subsidiary Secures Extension for NCD Maturity Date Setco Automotive Limited announced that its subsidiary, Setco Auto Systems Private Limited (SASPL), has received approval to extend the maturity date of its Non-Convertible Debentures (NCDs). The extension was approved through a circular resolution dated March 17, 2026, by the Board of Directors of SASPL, with the consent of the Debenture Holders and the Debenture Trustee.The maturity/redemption dates of the NCDs have been extended from March 31, 2026, to May 31, 2026. This adjustment is subject to receiving necessary in-principle approval(s) from the Stock Exchange(s).Source:

Indo Rama Synthetics (India) Limited Sets Cut-off Date for Postal Ballot Indo Rama Synthetics (India) Limited announced that its Board of Directors approved a Postal Ballot Notice on March 17, 2026, seeking shareholder approval for several resolutions. The resolutions include the appointment of Mr. Vipin Kumar as a Non-Executive, Non-Independent Director and Mr. Sanjay Gupta as a Whole-Time Director.March 20, 2026, has been designated as the cut-off date to determine member eligibility for electronic and postal voting. The company will distribute the Postal Ballot Notice, accompanied by an explanatory statement and detailed voting instructions, to registered members as of the cut-off date. The company’s stock code is NSE: INDORAMA and...

AstraZeneca India Receives Approval for Expanded Imfinzi Indication AstraZeneca Pharma India Limited announced on March 16, 2026, that it has received permission from the Central Drugs Standard Control Organisation, Directorate General of Health Services, Government of India, to import and distribute Durvalumab Solution for Infusion 120 mg/2.4 mL and 500 mg/10 mL, marketed as Imfinzi, for an additional indication.The approval allows for the treatment of patients with unresectable hepatocellular carcinoma (uHCC) who have not received prior systemic therapy. This expanded indication paves the way for the marketing of Imfinzi in India, pending receipt of related statutory approvals.Source: